Detalhe da pesquisa
1.
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.
J Virol
; 94(9)2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32051265
2.
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
Proc Natl Acad Sci U S A
; 115(24): 6267-6272, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29712861
3.
Breast Milk and Saliva Lactoferrin Levels and Postnatal Cytomegalovirus Infection.
Am J Perinatol
; 38(10): 1070-1077, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32069486
4.
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.
J Virol
; 93(5)2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518646
5.
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
J Virol
; 92(1)2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29021402
6.
Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans.
Sci Transl Med
; 12(568)2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148624
7.
Natural history of postnatal rhesus cytomegalovirus shedding by dams and acquisition by infant rhesus monkeys.
PLoS One
; 13(10): e0206330, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30356332
8.
Systemic administration of an HIV-1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization.
Mucosal Immunol
; 10(1): 228-237, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27072605